Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes
- PMID: 20019340
 - PMCID: PMC2830401
 - DOI: 10.1164/rccm.200909-1423OC
 
Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes
Abstract
Rationale: Obstructive sleep apnea (OSA), a treatable sleep disorder that is associated with alterations in glucose metabolism in individuals without diabetes, is a highly prevalent comorbidity of type 2 diabetes. However, it is not known whether the severity of OSA is a predictor of glycemic control in patients with diabetes.
Objectives: To determine the impact of OSA on hemoglobin A1c (HbA1c), the major clinical indicator of glycemic control, in patients with type 2 diabetes.
Methods: We performed polysomnography studies and measured HbA1c in 60 consecutive patients with diabetes recruited from outpatient clinics between February 2007 and August 2009.
Measurements and main results: A total of 77% of patients with diabetes had OSA (apnea-hypopnea index [AHI] > or =5). Increasing OSA severity was associated with poorer glucose control, after controlling for age, sex, race, body mass index, number of diabetes medications, level of exercise, years of diabetes and total sleep time. Compared with patients without OSA, the adjusted mean HbA1c was increased by 1.49% (P = 0.0028) in patients with mild OSA, 1.93% (P = 0.0033) in patients with moderate OSA, and 3.69% (P < 0.0001) in patients with severe OSA (P < 0.0001 for linear trend). Measures of OSA severity, including total AHI (P = 0.004), rapid eye movement AHI (P = 0.005), and the oxygen desaturation index during total and rapid eye movement sleep (P = 0.005 and P = 0.008, respectively) were positively correlated with increasing HbA1c levels.
Conclusions: In patients with type 2 diabetes, increasing severity of OSA is associated with poorer glucose control, independent of adiposity and other confounders, with effect sizes comparable to those of widely used hypoglycemic drugs.
Figures
              
              
              
              
                
                
                
              
              
              
              
                
                
                Comment in
- 
  
  Diabetes in obstructive sleep apnea.Am J Respir Crit Care Med. 2010 Jul 15;182(2):286-7. doi: 10.1164/ajrccm.182.2.286a. Am J Respir Crit Care Med. 2010. PMID: 20634501 No abstract available.
 - 
  
  Obstructive sleep apnea aggravates glycemic control across the continuum of glucose homeostasis.Am J Respir Crit Care Med. 2010 Jul 15;182(2):286. doi: 10.1164/ajrccm.182.2.286. Am J Respir Crit Care Med. 2010. PMID: 20634502 No abstract available.
 - 
  
  Diabetes, sleep apnea, and glucose control.Am J Respir Crit Care Med. 2010 Jul 15;182(2):287. doi: 10.1164/ajrccm.182.2.287. Am J Respir Crit Care Med. 2010. PMID: 20634503 No abstract available.
 
References
- 
    
- Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007;356:2457–2471. - PubMed
 
 - 
    
- Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, Ewy GA, Howard BV, Punjabi NM. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 2003;26:702–709. - PubMed
 
 - 
    
- Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 2007;13:355–362. - PubMed
 
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
